HomeBUSINESS
BUSINESS

Shionogi, UMN Pharma Conclude Capital Alliance; Tie Up in Infectious Disease Field
(Nov.2.2017)

Shionogi and the biotech startup UMN Pharma on October 31 announced a capital investment and business alliance agreement. Under the agreement, UMN Pharma will allocate 600,000 shares of common stock and a first issuance of convertible bonds with stock acquisition rights to Shionogi, which is expected to invest around 1.6 billion yen for the acquisition ...
(LOG IN FOR FULL STORY)